Two more experimental drugs for #alzheimers have failed: https://t.co/MgIVqUlBcG. A sad reminder in the #lifesciences industry that the overall chance of a drug entering clinical development will be approved for marketing is just under 12 percent via @TuftsCSDD.
We are proud to partner with Yvonne McLean Florence of @sisters_R_us! Check out this feature of her in @PhillyInquirer. https://t.co/BRttG1aOXP #cancersurvivor
We're proud to partner with @RobLong47 of @UpliftingAth and support their mission to inspire the #raredisease community with hope through the power of sport. WATCH his compelling story. https://t.co/rsw6t3IOOZ #WeTackleRare
Thank you, @MikeKellyPA, for speaking up for patients today. Representative Kelly read a letter from a patient advocate to show how #HR3 could stifle innovation for patients who rely on the hope of new treatments and cures. @UMDF
When Dr. @DavidFajgenbaum was diagnosed with a rare disease called #Castlemans, he spearheaded the search for a cure—and became a champion for a new approach to medical research. You can read about his journey in his new book, coming out Sept. 10th: https://t.co/UJwjKI8mka
My inspirations behind why I work so hard chasing my cure, Amelia and Caitlin, came by when I was recording the audiobook for #ChasingMyCure. Amelia may or may not be making a small cameo at the end. Pre-order the audiobook and see if she makes the cut at https://t.co/cIcAZwqyLy
Day 3 of #BIO2019 today with CEO of @VenatoRxPharma, Dr. Burns, presenting on his Malvern-based antibacterial & antiviral drug research and development company.
Attn #PittCon2019 go-ers! #WWFHPA is looking for patients, survivors, and caregivers in PA to tell their stories and urge our elected officials to support policies that protect patients like you! Please join us by completing this form: https://t.co/nuzGhOAJx2
.@CSLBehring sat down with @DavidFajgenbaum of @CureCastleman who received a research grant from the 2018 @UpliftingAth Young Investigator Draft. Read on to learn how Fajgenbaum has lived in remission from his rare disease since 2014: https://t.co/qvyjSt1en2 #WeTackleRare
We're proud to support @DavidFajgenbaum in the 5th annual Beating Castleman's Together Summit at @PennMedicine on Friday. Register here: https://t.co/WUwGRWbr4d @CureCastleman